Friday, November 22, 2024

AIIMS Infosys Oncology Chair for UK-based doctor Ranjit Manchanda

Manchanda’s core work includes development of surgical prevention strategies for ovarian cancer, the second most common gynaecological cancer in India

Leading India-born gynaecological oncologist Ranjit Manchanda from London’s Cancer Research UK Barts Centre has bagged the prestigious Infosys Chair in Oncology at All India Institute of Medical Sciences, New Delhi.

An alumnus of AIIMS New Delhi, Manchanda, completed his MBBS and MD from AIIMS in 1990s before proceeding to the University College London, UK for PhD in gynaecological oncology.

.

His core work includes population based germ line testing for risk prediction, targeted screening and cancer prevention; developing targeted surgical prevention strategies for ovarian and endometrial cancer; developing genetic testing strategies as cancer diagnosis and prevention and management of familial gynaecological cancer.

Currently Professor, Gynaecological Oncology at the Wolfson Institute of Population Health at Queen Mary University of London and Consultant Gynaecological Oncologist at Barts Health National Health Services Trust, Manchanda is leading several crucial research projects, early detection of ovarian cancer among them.

“This award means a lot to me and it is an honour and privilege to have received it. I am excited at the opportunity to work with colleagues at AIIMS across both clinical and academic domains, and bring our institutes together with the common aim to reduce the burden of disease and improve the lives of women affected by gynaecological cancer,” Manchanda said.

His work at Infosys Chair will support the division of Gynaecological Oncology at AIIMS It will aid early screening strategies for ovarian cancer, the second most common gynaecological cancer in India and a leading cause of death from cancer in Indian women with 3.34 per cent (24,015) of cancer deaths in one year.

Advanced ovarian cancer has a dismal prognosis, with the highest case fatality ratio amongst all gynaecological cancers globally – which explains the criticality of Manchanda’s expertise in the area.

**********************************************************************

Readers

These are extraordinary times. All of us have to rely on high-impact, trustworthy journalism. And this is especially true of the Indian Diaspora. Members of the Indian community overseas cannot be fed with inaccurate news.

Pravasi Samwad is a venture that has no shareholders. It is the result of an impassioned initiative of a handful of Indian journalists spread around the world.  We have taken the small step forward with the pledge to provide news with accuracy, free from political and commercial influence. Our aim is to keep you, our readers, informed about developments at ‘home’ and across the world that affect you.

Please help us to keep our journalism independent and free.

In these difficult times, to run a news website requires finances. While every contribution, big or small, will makes a difference, we request our readers to put us in touch with advertisers worldwide. It will be a great help.

For more information: pravasisamwad00@gmail.com

David Solomon
David Solomon
(For over four decades, David Solomon’s insightful stories about people, places, animals –in fact almost anything and everything in India and abroad – as a journalist and traveler, continue to engross, thrill, and delight people like sparkling wine. Photography is his passion.)

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

EDITOR'S CHOICE